Outcomes of salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory primary mediastinal large B cell lymphoma (PMLCL) are inferior to diffuse large B cell lymphoma (DLBCL).

被引：0
|
作者：
Kuruvilla, J
Nagy, T
Pintilie, M
Keating, A
Crump, M
机构：
[1] Univ Toronto, Princess Margaret Hosp, Autologous Blood & Marrow Transplant Program, Toronto, ON, Canada
[2] Princess Margaret Hosp, Clin Study Coordinat, Toronto, ON M4X 1K9, Canada
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.2085.2085
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2085
引用
收藏
页码：590A / 590A
页数：1
相关论文
共 50 条
  • [21] Primary mediastinal large B-cell lymphoma: role of autologous stem cell transplantation
    Cobo, T
    De Paz, R
    Canales, M
    Martin, M
    Lopez, A
    Hernandez, D
    Garcia-Bustos, J
    Hernandez-Navarro, F
    BONE MARROW TRANSPLANTATION, 2004, 33 : S352 - S352
  • [22] Consolidative Radiotherapy After Autologous Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B-cell Lymphoma
    Coutu, Brendan G.
    Wilke, Christopher T.
    Yuan, Jianling
    Cao, Qing
    Vernon, Matthew R.
    Lee, Chung
    Bachanova, Veronika
    Dusenbery, Kathryn E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : 65 - 73
  • [23] Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
    Yuan, Xianggui
    Li, Xian
    Huang, Yurong
    Jin, Xueli
    Liu, Hui
    Zhao, Aiqi
    Zhang, Weiping
    Qian, Wenbin
    Liang, Yun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Effect of rituximab (R) on clinical outcomes after autologous stem cell transplantation (ASCT) in pts with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
    Adegbola, O.
    Andreadis, C.
    Schuster, S. J.
    Chong, E. A.
    Nasta, S. D.
    Porter, D. L.
    Luger, S. M.
    Tsai, D. E.
    Cunningham, K.
    Stadtmauer, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Outcome of salvage therapy for relapsed or refractory peripheral T-cell lymphoma (PTCL), anaplastic large cell lymphoma (ALCL), and diffuse large B-cell lymphoma (DLBCL).
    Wu, G.
    Kuruvilla, J.
    Nagy, T.
    Keating, A.
    Crump, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 348S - 348S
  • [26] Outcomes of autologous hematopoietic cell transplantation (AHCT) in elderly patients with diffuse large B cell lymphoma (DLBCL)
    Munshi, P.
    Ahn, K.
    Kharfan-Dabaja, M.
    Herrera, A.
    Sauter, C.
    Hamadani, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 66 - 66
  • [27] SALVAGE REGIMEN WITH AUTOLOGOUS STEM CELL TRANSPLANTATION WITH OR WITHOUT RITUXIMAB MAINTENANCE FOR RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): CORAL FINAL REPORT
    Gisselbrecht, C.
    Glass, B.
    Fournier, M.
    Gill, D.
    Linch, D.
    Trneny, M.
    Bosly, A.
    Shpilberg, O.
    Hagberg, H.
    Ketterer, N.
    Ma, D.
    Gaulard, P.
    Moskowitz, C.
    ANNALS OF ONCOLOGY, 2011, 22 : 107 - 107
  • [28] High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma
    Shi, Yi-Fen
    Zhou, Shu-Juan
    Sun, Lan
    Yu, Kang
    Chen, Yi
    MEDICINA CLINICA, 2020, 155 (06): : 235 - 241
  • [29] Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma
    Desai, Sanjal H.
    Mwangi, Raphael
    Smith, Alexandra N.
    Maurer, Matthew J.
    Farooq, Umar
    King, Rebecca L.
    Cerhan, James R.
    Feldman, Andrew L.
    Habermann, Thomas M.
    Thompson, Carrie A.
    Wang, Yucai
    Ansell, Stephen M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (01) : 39 - 49
  • [30] Autologous stem cell transplantation for poor risk primary mediastinal large B cell lymphoma with sclerosis
    Cairoli, R
    Grillo, G
    Marenco, P
    Tedeschi, A
    Gargantini, L
    Tresoldi, E
    Morra, E
    BONE MARROW TRANSPLANTATION, 2003, 31 : S73 - S73
12345